Author: admin

Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. BackgroundDoxorubicin (DOX), an anthracycline-based chemotherapeutic agent, has been widely used as a first-line treatment for several cancers, including hematological and solid tumors, but its clinical utility is limited by severe cardiotoxicity and …Read Original Source

Read More

Journal of Pharmacology and Pharmacotherapeutics, Ahead of Print. Background/PurposeAlzheimer’s disease (AD) is a long-term neurodegenerative condition that leads to the gradual deterioration of nerve cells. The goal of this study is to use computational drug discovery (CDD) techniques to discover lead compounds that …Read Original Source

Read More